L.V. Prasad Eye Institute (LVPEI), Hyderabad, Telangana, India.
Association for Innovation and Biomedical Research on Light and Image (AIBILI), Coimbra, Portugal.
Br J Ophthalmol. 2019 Feb;103(2):222-226. doi: 10.1136/bjophthalmol-2018-311887. Epub 2018 Apr 26.
To analyse retinopathy phenotypes and microaneurysm (MA) turnover in mild non-proliferative diabetic retinopathy (NPDR) as predictors of progression to diabetic central-involved macular oedema (CIMO) in patients with type 2 diabetes mellitus (DM) in two different ethnic populations.
205 patients with type 2 DM and mild NPDR were followed in a prospective observational study for 2 years or until development of CIMO, in two centres from different regions of the world. Ophthalmological examinations, including best-corrected visual acuity (BCVA), fundus photography with RetmarkerDR analysis, and optical coherence tomography (OCT), were performed at baseline and 6 12 and 24 months.
158 eyes/patients reached either the study endpoint, CIMO (24) or performed the last study visit (24-month visit) without developing CIMO (134). From the eyes/patients in analysis, 27 eyes (17.1%) progressed to more advanced ETDRS (Early Treatment Diabetic Retinopathy Study) levels: 6 progressed to mild NPDR (level 35), 15 progressed to moderate NPDR (level 43), 5 progressed to moderately severe NPDR (level 47) and 1 progressed to high risk PDR (level 71). Worsening in ETDRS level is associated with phenotype C (p=0.005). From the 130 eyes/patients with a low MA turnover, 18 (13.8%) eyes/patients had an increase in ETDRS level, and from the 19 eyes/patients with a high MA turnover, 9 (47.4%) had an increase in ETDRS level (p<0.001).
Eyes in the initial stages of diabetic retinopathy show different phenotypes with different risks for progression to CIMO. In phenotype C, MA turnover correlates with ETDRS grading worsening and development of CIMO.
分析 2 型糖尿病(DM)患者轻度非增生性糖尿病视网膜病变(NPDR)的视网膜病变表型和微动脉瘤(MA)转换,以预测 2 个不同种族人群中 NPDR 患者向糖尿病黄斑水肿(CIMO)进展的可能性。
205 例 2 型 DM 伴轻度 NPDR 患者在两个中心进行前瞻性观察研究,随访 2 年或直至发生 CIMO。眼科检查包括最佳矫正视力(BCVA)、RetmarkerDR 眼底照相分析和光学相干断层扫描(OCT),基线时和 6、12 和 24 个月进行检查。
158 只眼/患者达到研究终点,CIMO(24 只眼)或进行最后一次研究访问(24 个月访问)而未发生 CIMO(134 只眼)。在分析的眼/患者中,27 只眼(17.1%)进展为更高级别的 ETDRS(糖尿病性视网膜病变早期治疗研究)分期:6 只眼进展为轻度 NPDR(35 期),15 只眼进展为中度 NPDR(43 期),5 只眼进展为中度重度 NPDR(47 期),1 只眼进展为高危 PDR(71 期)。ETDRS 分期恶化与表型 C 相关(p=0.005)。在 MA 转换率低的 130 只眼/患者中,18 只眼/患者(13.8%)的 ETDRS 分期升高,在 MA 转换率高的 19 只眼/患者中,9 只眼/患者(47.4%)的 ETDRS 分期升高(p<0.001)。
糖尿病视网膜病变早期阶段的眼睛表现出不同的表型,向 CIMO 进展的风险也不同。在表型 C 中,MA 转换与 ETDRS 分级恶化和 CIMO 的发生相关。